Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results
U.S. stocks surged Monday, led by a 2.1% S&P 500 gain; NRG jumped on strong results, while Zura Bio plunged 75% after trial failures.
Stocks · News reference
8-K filing — Iambic Therapeutics, Inc. (IAM)
Filed: 2026-10-16 AccNo: 0001193125-26-424242 Size: 435 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CNH Industrial, Planet Labs, Ferguson Enterprises And Other Big Stocks Moving Higher On Monday
U.S. stocks rallied Monday; CNH surged 13.5% after strong Q3 results and raised guidance, while several stocks posted double-digit gains.
This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiated bullish coverage on IAM, AMRO, CWH, SUPN, issuing Buy, Outperform or Overweight ratings with price targets.
JP Morgan Initiates Coverage On Iambic Therapeutics with Overweight Rating, Announces Price Target of $22
Citigroup Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $22
B of A Securities Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $30